跳至主要内容
临床试验/NCT00758953
NCT00758953已完成2 期

Pain Associated With Endometriosis

Lumara Health, Inc.0 个研究点目标入组 66 人开始时间: 2007年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
66
主要终点
Pain associated with endometriosis

研究概览

简要总结

This study will evaluate the efficacy and safety of an investigational medication compared with placebo in the treatment of pain associated with endometriosis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Menstruating female 18-50 years of age,
  • Regular cycle length of 21 to 35 days with menstrual bleeding that typically lasts no more than 7 days,
  • Has pain associated with endometriosis,
  • Has a documented history consistent with endometriosis,

排除标准

  • Is pregnant or lactating,
  • Has a history of or has active thrombosis

研究组 & 干预措施

1

Experimental

干预措施: Danazol Once Weekly (Drug)

2

Experimental

干预措施: Danazol Twice Weekly (Drug)

3

Placebo Comparator

干预措施: Placebo Once Weekly (Drug)

4

Placebo Comparator

干预措施: Placebo Twice Weekly (Drug)

结局指标

主要结局

Pain associated with endometriosis

时间窗: 3 months of treatment

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

相似试验